慢性肺性阿斯伯吉洛症:临床表现和管理
Terry J Evans1, AbdulAzeez Lawal2, Chris Kosmidis2,3
1Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Mahosot Hospital, Vientiane, Lao PDR.
Seminars in respiratory and critical care medicine
|December 28, 2023
概括
慢性肺炎 (CPA) 是一种严重的肺部感染,经常被忽视,特别是在低收入国家. 早期识别和适当的抗真菌治疗对于管理这种疾病和改善患者的治疗结果至关重要.
科学领域:
- 肺病学和传染病的研究
- 菌类学 菌类学是指菌类学.
- 医学诊断和治疗学
背景情况:
- 慢性肺阿斯伯吉洛症 (CPA) 是一系列由阿斯伯吉洛菌在患有慢性肺病的患者中引起的肺部疾病.
- 在全球范围内,CPA得到越来越多的认可,但诊断不足仍然是一个重大问题,特别是在低收入和中等收入国家,它可能被误诊为结核病 (TB).
- 由于因结核病治疗中断而增加的肺损伤,COVID-19大流行可能会加剧CPA风险.
研究的目的:
- 审查慢性肺阿斯伯吉洛症 (CPA) 的临床综合征,诊断和管理.
- 为突出诊断挑战和CPA的当前治疗建议.
- 确定促进CPA理解和治疗的关键研究重点.
主要方法:
- 对CPA的临床表现,诊断标准和差异诊断的审查.
- 分析当前的抗真菌治疗策略,包括一线和替代药物,并管理副作用.
- 讨论手术考虑和治疗后复发模式.
- 识别CPA病因,宿主因子和新疗法的新兴研究领域.
主要成果:
- 经典的CPA呈现包括渐进的肺腔,全身和呼吸系统症状持续超过3个月.
- 诊断依赖于血清Aspergillus免疫球蛋白G,因为唾液培养具有低灵敏度;差异诊断范围广泛.
- 抗真菌治疗旨在改善症状并阻止疾病的进展,约20%的病例复发.
结论:
- CPA是慢性肺病的一个未被认可但重要的并发症,需要提高诊断意识和及时干预.
- 有效的管理包括适当的抗真菌治疗,仔细监测副作用和耐药性,并考虑手术选择.
- 对免疫因素,病原和新型治疗方法的进一步研究对于改善CPA患者的治疗结果至关重要.
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:20COPD: Pathogenesis and Clinical Features
279
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
279
01:24Cystic Fibrosis: Management
166
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
166
01:26COPD: Management Using Bronchodilators and Corticosteroids
208
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
208
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K